Back to Search Start Over

Roche delays DMD drug deadline, decides to rejig MS trials because of Ukraine war.

Authors :
Waldron, James
Source :
FierceBiotech; 4/25/2022, pN.PAG-N.PAG, 1p
Publication Year :
2022

Abstract

Roche has pushed back the regulatory timeline for its Duchenne muscular dystrophy treatment by a year. [ABSTRACT FROM AUTHOR]

Subjects

Subjects :
DUCHENNE muscular dystrophy
DEADLINES
DRUGS
MULTIPLE sclerosis

Details

Language :
English
Database :
Complementary Index
Journal :
FierceBiotech
Publication Type :
Periodical
Accession number :
156499935

Tools

Authors Abstract Subjects Details